Quality assurance of drug therapy for patients with asthma. Health economic analysis;Kvalitetssikring af astmapatienters laegemiddelbehandling. Sundhedsøkonomisk analyse.

Ugeskrift for laeger

Volumn 162, Issue 4, 2000, Pages 480-486

  Sondergaard B ^a   Thorleifsson, S ^a   Herborg, H ^a   Frokjaer B ^a   Hepler, C D ^a   Ersboll B K ^a  

^a Pharmakon as   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DENMARK; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT SATISFACTION; PHARMACY;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COMMUNITY PHARMACY SERVICES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DENMARK; DRUG COSTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY ASSURANCE, HEALTH CARE;

EID: 0034707470     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)